BioSmart Increases Stake in Omnisystem to 26.39% Acquiring 1.75 Million Shares via Open Market Purchases to Strengthen Management Control
BioSmart acquired an additional 1,754,294 shares of Omnisystem through open market purchases from July 9 to 15, 2026, increasing its stake from 23.41% to 26.39%. The total acquisition cost was approximately 1.57 billion KRW, funded entirely through internal cash reserves.
The purpose is to exercise influence as the largest shareholder, signaling commitment to management control. While short-term price impact may be limited, strengthened control could contribute to long-term operational stability.
As of end-2025, BioSmart reported total assets of approximately 309.9 billion KRW, total liabilities of 122.2 billion KRW, and equity of 187.7 billion KRW, indicating a healthy financial position.
Additionally, Omnisystem canceled 55,087 treasury shares on March 26, 2026, reducing total outstanding shares. This action enhances shareholder value.
[AI Summary]BioSmart's open market purchase solidifies its controlling stake using only self-funded capital, reducing financial risk. The treasury share cancellation further supports shareholder interests. Investors should monitor potential further stake increases.